116 related articles for article (PubMed ID: 38359612)
1. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the ZNF148/PTX3 axis promotes malignant transformation of dendritic cells in glioma stem-like cells microenvironment.
Cheng S; Liu L; Wang D; Li Y; Li S; Yuan J; Huang S; Xu Z; Jia B; Li Z; Dong J
CNS Neurosci Ther; 2023 Sep; 29(9):2690-2704. PubMed ID: 37063077
[TBL] [Abstract][Full Text] [Related]
3. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment.
Castellani G; Buccarelli M; D'Alessandris QG; Ilari R; Cappannini A; Pedini F; Boe A; Lulli V; Parolini I; Giannetti S; Biffoni M; Zappavigna V; Marziali G; Pallini R; Ricci-Vitiani L
Cancer Cell Int; 2024 Feb; 24(1):72. PubMed ID: 38347567
[TBL] [Abstract][Full Text] [Related]
6. Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma.
Chen L; Tian X; Gong W; Sun B; Li G; Liu D; Guo P; He Y; Chen Z; Xia Y; Song T; Guo H
Cancer Biol Med; 2019 Feb; 16(1):89-100. PubMed ID: 31119049
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180
[TBL] [Abstract][Full Text] [Related]
9. Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma.
Pang L; Dunterman M; Xuan W; Gonzalez A; Lin Y; Hsu WH; Khan F; Hagan RS; Muller WA; Heimberger AB; Chen P
Cell Rep; 2023 Feb; 42(2):112127. PubMed ID: 36795563
[TBL] [Abstract][Full Text] [Related]
10. Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression.
Chen X; Hao A; Li X; Ye K; Zhao C; Yang H; Ma H; Hu L; Zhao Z; Hu L; Ye F; Sun Q; Zhang H; Wang H; Yao X; Fang Z
Theranostics; 2020; 10(3):998-1015. PubMed ID: 31938047
[No Abstract] [Full Text] [Related]
11. EMP3 as a prognostic biomarker correlates with EMT in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract][Full Text] [Related]
12. UTX inhibition suppresses proliferation and promotes apoptosis in patient-derived glioblastoma stem cells by modulating periostin expression.
Luan Y; Zhang H; Liu Y; Xue J; Wang K; Ma B; Ma K; Lu H; Chen X; Liu Y; Zhang Z
J Cell Physiol; 2024 Apr; 239(4):e31178. PubMed ID: 38214211
[TBL] [Abstract][Full Text] [Related]
13. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
15. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
16. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway.
Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B
J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.
Yang P; Kang W; Pan Y; Zhao X; Duan L
Cancer Manag Res; 2019; 11():8167-8179. PubMed ID: 31564976
[TBL] [Abstract][Full Text] [Related]
18. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
19. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
20. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
Visioli A; Trivieri N; Mencarelli G; Giani F; Copetti M; Palumbo O; Pracella R; Cariglia MG; Barile C; Mischitelli L; Soriano AA; Palumbo P; Legnani F; DiMeco F; Gorgoglione L; Pesole G; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2023 Sep; 42(1):244. PubMed ID: 37735434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
